CYNK-GDT

About Celularity

Celularity is a vertically integrated cell therapy company with a mission to harness the postpartum placenta to create scalable, off-the-shelf cellular medicines. Its achievements include a robust, GMP-capable manufacturing facility, a diverse pipeline of placental-derived cell therapies and biomaterials, and strategic financial moves to bolster its longevity-focused strategy. The company's core strategy is to overcome the traditional barriers of cell therapy—scale, cost, and patient-specific manufacturing—by utilizing a readily available, ethically non-controversial biological source.

Therapeutic Areas

Other Glioblastoma Multiforme (GBM) Drugs